Evidence map›Paper›PMID 33447334›Full record

ArticleThe Pan African medical journal2020

Research as a pillar of Lassa fever emergency response: lessons from Nigeria.

Adebola Tolulope Olayinka, Chioma Dan Nwafor, Adejoke Akano, Kamji Jan, Blessing Ebhodaghe, Kelly Elimian, Chinwe Ochu, Tochi Okwor, Oladipupo Ipadeola, Winifred Ukponu and 4 more

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Adebola Tolulope OlayinkaWorld Health Organisation, Abuja, Nigeria.
Chioma Dan NwaforNigeria Centre for Disease Control, Abuja, Nigeria.
Adejoke AkanoNigeria Centre for Disease Control, Abuja, Nigeria.
Kamji JanNigeria Centre for Disease Control, Abuja, Nigeria.
Blessing EbhodagheNigeria Centre for Disease Control, Abuja, Nigeria.
Kelly ElimianNigeria Centre for Disease Control, Abuja, Nigeria.
Chinwe OchuNigeria Centre for Disease Control, Abuja, Nigeria.
Tochi OkworNigeria Centre for Disease Control, Abuja, Nigeria.
Oladipupo IpadeolaNigeria Centre for Disease Control, Abuja, Nigeria.
Winifred UkponuGeorgetown University, Abuja, Nigeria.
Ifeanyi OkudoWorld Health Organisation, Abuja, Nigeria.
Clement PeterWorld Health Organisation, Abuja, Nigeria.
Elsie IloriNigeria Centre for Disease Control, Abuja, Nigeria.
Chikwe IhekweazuNigeria Centre for Disease Control, Abuja, Nigeria.
Nigeria Centre for Disease Control · NGWorld Health Organization - Nigeria · NGGeorgetown University · US

Funding

World Health Organization 001
6 · The paper itself

Abstract

Emerging and re-emerging infectious diseases are becoming more frequent and developing countries are especially at increased risk. A recurring infectious disease outbreak in Nigeria has been that of Lassa fever (LF), a disease that is endemic in Nigeria and other West African countries. Nigeria, between 1

Indexed as

Disease OutbreaksHumansLassa FeverNigeriaResearchResearch Designhealth emergenciesinfectious disease outbreaksLassa feveroperational research

Identifiers

PMID33447334
PMCPMC7778227
OpenAlexW3097772848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.